AskAt Inc. announced today that AskAt received a notice of allowance dated October 23, 2020 from the Canadian Intellectual Property Office (CIPO) in connection with the Application No. 2,907,783, a use patent of COX-2 inhibitor (AAT-076) for ocular diseases.